TABLE 1.
Demographic, clinical and treatment characteristics of the study sample.
| Variables | Mean (SD)/N (%) |
| Demographics | |
| Age at study assessment | 40.53 (7.79) |
| Female sex | 58 (57.4) |
| Years of education | 11.48 (3.50) |
| Premorbid, onset and illness profiles | |
| PAS overall score | 0.32 (0.17) |
| Age at onset of psychosis | 35.28 (8.17) |
| Duration of untreated psychosis, daysa | 151 |
| Psychiatric diagnosisb | |
| Schizophrenia-spectrum disorder | 64 (63.4) |
| Other non-affective psychoses | 37 (36.6) |
| Past history of psychiatric admission | 68 (67.3) |
| Family history of psychotic disorder | 26 (25.7) |
| Symptom and functional levels | |
| PANSS positive symptom scorec | 8.82 (3.72) |
| PANSS disorganization scorec | 7.87 (1.45) |
| BNSS total score | 12.30 (11.96) |
| CDSS total score | 1.88 (2.94) |
| SUMD score | 4.57 (1.83) |
| SOFAS score | 60.88 (10.87) |
| Treatment characteristics | |
| Use of second-generation antipsychotic | 84 (83.2) |
| Chlorpromazine equivalents, mg | 419.63 (646.78) |
| SAS mean score | 0.03 (0.14) |
| BARS global score | 0.09 (0.47) |
| AIMS total score | 0.27 (1.66) |
aDuration of untreated psychosis (DUP) is presented in median.
bSchizophrenia-spectrum disorder included schizophrenia (n = 61) and schizoaffective disorder (n = 3). Other non-affective psychoses included delusional disorder (n = 9), brief psychotic disorder (n = 14) and psychosis not otherwise specified (n = 14).
cPANSS positive symptom and disorganization dimensions were derived on the basis of a previous factor-analytic study in early psychosis patients (65).
AIMS, abnormal involuntary movement scale; BARS, Barnes akathisia rating scale; BNSS, brief negative symptom scale; CDSS, Calgary Depression Scale for Schizophrenia; PANSS, positive and negative syndrome scale; PAS, premorbid adjustment scale; SAS, Simpson-Angus Scale; SOFAS, social and occupational functioning assessment scale; SUMD, Scale to Assess Unawareness of Mental Disorder.